Page last updated: 2024-10-27

fomepizole and Chronic Disease

fomepizole has been researched along with Chronic Disease in 1 studies

Fomepizole: A pyrazole and competitive inhibitor of ALCOHOL DEHYDROGENASE that is used for the treatment of poisoning by ETHYLENE GLYCOL or METHANOL.
fomepizole : A member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
" Methanol toxicity initially is not characterized by severe toxic manifestations."2.38Methanol toxicity. Agency for Toxic Substances and Disease Registry. ( , 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Reviews

1 review available for fomepizole and Chronic Disease

ArticleYear
Methanol toxicity. Agency for Toxic Substances and Disease Registry.
    American family physician, 1993, Volume: 47, Issue:1

    Topics: Acute Disease; Aged; Chronic Disease; Clinical Protocols; Environmental Exposure; Ethanol; Family Pr

1993